Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04889222 · ClinicalTrials.gov registry record

Effect of Skin Pigmentation and Race/Ethnicity Factors on the Accuracy of Masimo Pulse Oximeters

A clinical trial, sponsored by Masimo Corporation.

Terminated
Registry status
54
Enrollment target

NCT04889222 is a clinical trial that was terminated before completion, run by Masimo Corporation. The registered enrollment target is 54 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04889222 was terminated before completion, sponsored by Masimo Corporation.

TERMINATED
Registry status
54 participants
Enrollment target

Study Summary

This study is designed to compare the accuracy of a noninvasive measurement of oxygen saturation compared to reference values obtained by a laboratory blood gas analyzer. Subgroups will be analyzed by skin pigmentation and self-identified race/ethnicity information. Study procedures follow ISO-80601-2-61:2011 standard requirements for basic safety and essential performance of pulse oximeter equipment. Arterial blood samples will be collected from subjects while undergoing a controlled desaturation procedure wherein the concentration of oxygen inhaled is slowly reduced until the subject's arterial oxygen concentration is approximately 70%.

Interventions

  • DEVICE INVSENSOR00050
  • DEVICE RD SET SpO2

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2021-04-05
Est. Completion 2021-04-29

Sponsor

Masimo Corporation

96 total trials

What the Registry Record Tells You About NCT04889222

The ClinicalTrials.gov registry entry for NCT04889222 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which INVSENSOR00050 is the first listed.

NCT04889222 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04889222 about?

NCT04889222 is a clinical study titled "Effect of Skin Pigmentation and Race/Ethnicity Factors on the Accuracy of Masimo Pulse Oximeters". This study is designed to compare the accuracy of a noninvasive measurement of oxygen saturation compared to reference values obtained by a laboratory blood gas analyzer. Subgroups will be analyzed by skin pigmentation and self-identified race/ethnicity information. Study procedures follow ISO-8060...

What is the current status of trial NCT04889222?

This trial is currently terminated. The enrollment target is 54 participants. The study started on 2021-04-05. Estimated completion is 2021-04-29.

What interventions are being tested in trial NCT04889222?

The interventions under investigation include: INVSENSOR00050 (DEVICE), RD SET SpO2 (DEVICE).

Who is sponsoring clinical trial NCT04889222?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.